DOCSLIB.ORG

Bibliography on Smoking and Health. INSTITUTION Public Health Service (DHEW), Rockville, Md

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Bibliography on Smoking and Health. INSTITUTION Public Health Service (DHEW), Rockville, Md DOCUMENT RESUME ED 068 857 CG 007 558 TITLE Bibliography on Smoking and Health. INSTITUTION Public Health Service (DHEW), Rockville, Md. National Clearinghouse for Smoking and Health. PUB DATE 71 NOTE 344p. AVAILABLE FROMSuperintendent of Documents, U. S. Government Printing Office, Washington, D. C. 20402 EDRS PRICE MF-S0.65 HC- $13.16 DESCRIPTORS Bibliographic Coupling; *Bibliographies; Booklists; Disease Control; Disease Rate; Diseases; Health; *Health Education; Indexing; Information Retrieval; *Literature Reviews; *Smoking; *Tobacco ABSTRACT This Bibliography includes all of the items added to the Technical Information Center of the National Clearinghouse for Smoking and Health from January through December 1971. The publication is broken down into eleven major categories. These are: (1) chemistry, pharmacology and toxicology; (2) mortality and morbidity;(3) neoplastic diseases;(4) non-neoplastic respiratory diseases; (5) cardiovascular diseases; (6) other diseases and conditions;(7) behavioral and educational research;(8) tobacco economics;(9) bills and legislation; and (10) general references. Also included in this bibliography are a cumulative author and organizational index and a cumulative subject index. U00 1971 NATIONAL CLEARINGHOUSE FOR SMOKING AND HEALTH BIBLIOGRAPHY on SMOKING AND HEALTH U.S. DEPARTMENT OF HEALTII. EDUCATION & WELFARE OFFICE OF EDUCATION THIS DOCUMENT HAS BEEN REPRO- DUCED EXACTLY AS RECEIVED FROM THE PERSON OR ORGANIZATION ORIG INATING IT. POINTS OF VIEW OR OPIN IONS STATED DO NOT NECESSARILY REPRESENT OFFICIAL OFFICE OF EDU- CATION POSITION OR POLICY. U.S. DEPARTMENT OF HEALTH, EDUCATION, AND WELFARE Public Health Service Health Services and Mental Health Administration FILMED FROM BEST AVAILABLE COPY 1 PREFACE This Bibliography includes all of the items added to theTechnical Information Center of the National Clearinghouse for Smoking and Health fromJanuary through December 1971. Earlier volumes still available for purchase throughthe Superintendent of Docu- ments, Government Printing Office, include thevolumes for 1968, 1969 (Parts I and II), and 1970. These may be ordered by requesting fromthe Government Printing Office, Public Health Service Publication No. 1124, BibliographySeries No. 45, plus the year desired. Information on the availability of articles listed in thisBibliography may be obtained by writing or calling the Technical Information Center at theClearinghouse. Technical Information Center National Clearinghouse for Smoking and Health 5401 Westbard Avenue Bethesda, Maryland 20016 301-496-7941 ti For ado by the Superintendent of Documents, U.& Government Printing Mee, Washington, D.C. 20102 CONTENTS CHEMISTRY, PHARMACOLOGY AND TOXICOLOGY 1,33, 64,96,129,148, 179,208 MORTALITY AND MORBIDITY 7,41, 76,103,134,156,183,213 NEOPLASTIC DISEASES 9,43, 76,104,135,156, 184,213 NON-NEOPLASTIC RESPIRATORY DISEASES 13,47, 79,108,137,159, 188, 218 CARDIOVASCULAR DISEASES 19, 52,84,113,140,163, 193, 225 OTHER DISEASES AND CONDITIONS 25, 55, 88,119,142,169, 199, 229 BEHAVIORAL AND EDUCATIONAL RESEARCH 27,57,91,124,145,171,201,232 TOBACCO ECONOMICS 30,61,93,236 BILLS AND LEGISLATION 31,61,93,126,205 SMOKING CESSATION METHODS 31,62,94,126,177,205,236 GENERAL 31,63,95, 127,146,178,206,238 CUMULATIVE AUTHOR AND ORGANIZATIONAL INDEX 240 CUMULATIVE SUBJECT INDEX 301 CHEMISTRY, PHARMACOLOGY AND TOXICOLOGY 71-0001. Anastasov, A., Mokhnachev, LG. Sherstyanykh, Smoke.]Mitteilangen sus dem Gebeite der Lehenz. N. A. Izsledmie na Sustava na Alkaloidite v Tyutyu- mittehengtersuchung mod lbwiene 60(5):379-388. 1969, neviya Dim a Pomoshta na Gazovata Khromatografiya. German. [investigation of the Alkaloid Composition in Tobacco Smoke by Gas Chromatography.] Bulgarskl Tyutyun The acrolein and hydrocyanic acid content of cigarette 13(5):24-26, 1968, Bulgarian. smoke has been studied. The measurement of acrolein was carried out directly by chromatography while hydro- Gas chromatography was used to determine the com- cyanic acid in the gas and particulate phases was deter- position of all basic constituents present in cigarette mined by a colorimetric method. The hydrocyanic acid smoke, such as pyridine, alpha-picolinc.and berapicoline, content retained in the butt was also measured. In the gas with special attention given to the true alkaloids (nico- phase of the cigarettes without filters were found between tine, nomicotine, anabasine, metanicotine, etc.). The 90 and 230 micrograms of acrolein per cigarette. de- results are tabulated. A crepe filter reduced the nicotine pending on the kind of tobacco. The quantity of hydro- content of the smoke by about 20 percent and the con- cyanic acid found in main-stream smoke (gas and particu- tent of the other alkaloids from 20 to 57 percent. As far late phases) was between 150 and 350 micrograms per as the toxicity of nicotine and other alkaloids is con- cigarette. It was further established that the two com- cerned, such a filter on a cellulose base definitely renders pounds are appreciably reduced by the utilization of smoking less hazardous. filters containing the adsorbent materials. 71-0002. Anastasov, A., Pisklov, V. P., Mokhnachev, I. G. 71-0005. Banyai, A. L. Ominous Mesalliance: Inhalation lzsledvane na Puafinovite Vuglevodorodi v Glavnata of Carbon Monoxide From Motor Vehicles and Ciga- Struya na Tyutyuneviya Dim s Pomoshtta na Gazovata rettes. Chest 58(5):532, November 1970. Kluomatopafiya. [investigation of the Paraffin Hydro- carbons in Main-Stream Tobacco Smoke by Gas Chrome- Animal and human experiments hav'e shown that t opap hy .]Bulgarski Tyutyun13(11 ): 27-32,1968, carbon monoxide can lead to increased pulmonary artery Bulgarian. pressure,increasedheartrate andsystolicpressure. decreased metabolism, some myocardial fiber degenera- The peaks in the chromatogram disclosed that paraffin tion, hemorrhaging and necrosis of the myocardium, hydrocarbons containing 20 to 33 carbons, both straight increased blood viscosity, atheromatous changes. ECG and branched chain, were present in the smoke. Cellulose changes, inhibition of brain bioclectric activity, impair- filters increased the average values from 2.37 to 2.64 mg ment of cognitive and psychomotor areas of the brain and of higher hydrocarbons per gram tobacco. This indicates inhibition of alveolar macrophage function. Carboxy- that filters by their decomposition may cause a relative hemoglobin levels reach 4 to 6 percent in moderate increase of approximately 10 percent in higher hydro- smokers and up to 12 percent in heavy smokers. Carbon carbons. It was speculated, however, that the increase monoxide concentrations from motor vehicle exhausts, might be due not to filter decomposition but to hydro- especially during peak traffic hours, often exceed the carbons adsorbed inthe filters and later released as maximum allowable levels. smoking continued. 71-0006. Baribaud, L., Yacoub, M., Faure. J., Malinas, Y., 71-0003. Arsenyan, E.Kolichestveni lzmeneniya na Cau, G. L'Oxycubonemie de rEnfant Ne de Mere Alkaloidite pal Razlichni na Fermentatsiya na Orientalski Fumeuse. [Carboxyhemoglobinemia in the Child Born to Tyutyuni. [Quantitative Changes in the Alkaloid Content a Mother Who Smokes.]Afedechse Legale et Dommage of Oriental Tobacco With Different Curing Pro- Comore! 3(3):272-274. July-August-September, 1970. cesses.]Bulgarski Tyutyun 13(11):22-26, 1968, Bul- French. garian. While the average rate of carbon monoxide in non- The Bulgarian tobacco industry, aware of the health smoking women is 2.11 cm3/1000 cm3 of blood. and is hazards of smoking and its consequences on the industry's 352 for their children, this rate increases in smoking economic survival, has tested several curing methods in an mothers. Women who smoked from 11 to 20 cigarettes a attempt to lower the nicotine content of Bulgarian-grown day showed 11.67 cm3 of carbon monoxide per 1000 tobacco, These methods, including short, high-tempera- cm3 of blood, and their babies 15.13 cm3 of carbon ture curing, multi-step curing, and curing with various monoxide in the blood. This indicates that children born pauses, affect the enzyme activity and microorganisms to smoking mothers show an almost chronic intoxication present in the tobacco. The best results were obtained from carbon monoxide, which is present in tobacco with the short, high-temperature cure, w.dch reduced the smoke at 3.2 percent. Spontaneous abortions occurred in alkaloid content by almost 10 percent. 11 out of 27 smoking mothers, as compared to 7 out of 50 nonsmoking mothers. 710004. Artho, A., Koch, R. Ueber den Gehalt des Cigarettenrauches an Acrolein and Cyanwassentoff. 71-0007. Bastos, W. P., Ramos, A. 0. Isoaminile as In- [Acrolein and Hydrocyanic Acid Content in Cigarette hibitor of Musearinic and Nicotinic Ganglionic Re- ceptors. Pharmacology 4(1):39. 44,1970. 1 r. CHEMISTRY, PHARMACOLOGY AND TOXICOLOGY The tanglioplegic action of isoaminile was observed in 71-0011. Clia, B., Lemanccau, B. Etude par Resonance dogs and cats. The drug antagonizes Zioth muscarinic and Magnetique Nucleaire d'Isomeres Cancerogenes et non nicotinic ganglionic receptors in the superior cervical Cancerogenes (Dibenzacridines etDibenzanthracenes). ganglion of the cat, the adrenal responses to splanchnic (Study by Nuclear Magnetic Resonance of Carcinogenic nerve stimulation, and the hypertensive action of nico- and Non-Carcinogenic Isomers (Dibenzacridines and tine, acetylcholine and McN-A-343 (4-(m-chlorphenyl- Dibenzanthracenes).JComptes Rendus Herbdomadaires carbumoiloxy)2-butynyltrimethylammonium
Load more

Recommended publications
  • Roger Lee Papke Box 100267 JHM Health Science Center Gainesville, Florida 32610
    CURRICULUM VITAE Roger Lee Papke DEPARTMENT OF PHARMACOLOGY AND THERAPEUTICS UNIVERSITY OF FLORIDA SCHOOL OF MEDICINE Box 100267 J.H.M. Health Science Center Gainesville, Florida 32610 (352) 392-4712, FAX (352) 392-9696 [email protected] BIOGRAPHICAL DATA: Born: October 12, 1953, Kenmore, New York Married: December 24, 1980 to Clare Stokes Citizenship: U. S. A. EDUCATION: Starpoint Central School Pendleton, N. Y. Primary and Secondary N.Y.S. Regents Diploma 1971 New York University Washington Square College of Arts and Sciences 1971 - 1975 Majors in Biology and Classical Civilization Bachelor of Arts awarded May 1975 New York University Graduate school of Arts and Sciences 1975 - 1976 Thesis advisor: Dr. Fleur L. Strand Thesis title: An Alpha Adrenergic Response of Cardiac Muscle at an Alkaline pH Master of Science awarded May 1976 Cornell University Graduate School of Arts and Science 1976-1979: Section of Physiology Graduate Research Assistant in Reproductive Physiology Advisor: Dr. William Hansel Research topic: The endocrine control of delayed implantation in mink Cornell University Graduate School of Arts and Science 1979-1986: Section of Neurobiology and Behavior Thesis Advisor: Dr. Robert Oswald Primary research topic: Pharmacology of nicotinic acetylcholine receptors Thesis Title: The Gating of Single Channel Currents Through the Nicotinic Acetylcholine Receptors of BC3H-1 Cells: Effects of Agonists and Allosteric Ligands Ph.D. conferred January 1987 ACADEMIC APPOINTMENTS: 1987 Postdoctoral Research Associate: Department of Pharmacology,
    [Show full text]
  • Differential Effects of Alkaloids on Memory in Rodents
    www.nature.com/scientificreports OPEN Diferential efects of alkaloids on memory in rodents Patrick M. Callahan1,2, Alvin V. Terry Jr.1,2, Manuel C. Peitsch3, Julia Hoeng3* & Kyoko Koshibu3* Nicotinic acetylcholine receptors (nAChRs) play a critical role in the neuropharmacology of learning and memory. As such, naturally occurring alkaloids that regulate nAChR activity have gained interest for understanding and potentially improving memory function. In this study, we tested the acute efects of three known nicotinic alkaloids, nicotine, cotinine, and anatabine, in suppressing scopolamine-induced memory defcit in rodents by using two classic memory paradigms, Y-maze and novel object recognition (NOR) in mice and rats, respectively. We found that all compounds were able to suppress scopolamine-induced spatial memory defcit in the Y-maze spontaneous alternation paradigm. However, only nicotine was able to suppress the short-term object memory defcit in NOR, despite the higher doses of cotinine and anatabine used to account for their potential diferences in nAChR activity. These results indicate that cotinine and anatabine can uniquely regulate short-term spatial memory, while nicotine seems to have more robust and general role in memory regulation in rodents. Thus, nAChR-activating alkaloids may possess distinct procognitive properties in rodents, depending on the memory types examined. Te cholinergic system of the brain is a critical regulator of attention, memory, and higher-order cognitive processing, and its defcits are central to the etiology of dementia1. As such, nicotinic acetylcholine receptors (nAChRs) have gained much interest as a target of drug development 2. Neuronal nAChRs are pentameric pro- teins composed of various combinations of α (α2–α9) and β (β2–β4) nAChR subunits, diferentially expressed throughout the nervous system.
    [Show full text]
  • Editorial Current Clinical Management of Smoke Inhalation Injuries. A
    Editorial Current clinical management of smoke inhalation injuries. A reality check. Arietta Spinou1, Nikolaos G. Koulouris2 1. Health Sport and Bioscience, University of East London, London, UK 2. 1st Respiratory Medicine Department, National and Kapodistrian University of Athens Medical School, Athens, Greece Corresponding author: Dr Arietta Spinou Email: [email protected] Address: Stratford Campus, University of East London Health Sport and Bioscience Water Lane, Stratford, London E15 4LZ Words: 1502 References: 30 Keywords: burns, smoke inhalation injury, clinical management, physiotherapy To the Editor, A major disaster is happening at the moment, as the Camp Fire, Woolsey Fire and Hill Fire are burning in California. Camp Fire in Northern California has already burned 546.3 km2 and is the deadliest wildfire in the history of the state, with 48 fatalities and still counting (1). It was also only recently, in July 2018, when a fire entered the populated area of Mati, Greece, and created a wildland urban interface that caused 99 fatalities and numerous burns and smoke inhalation injuries. A few years ago, in August 2007, 67 people died in a megafire event in the Peloponnese region, Greece, which was created by 55 simultaneous large fires (based on size, intensity, environmental and socio-economic impact) (2). These and numerous other tragic incidents highlight the importance of our current clinical management in the victims of fire. Burns are categorised according to depth, and their severity depends on the extent (percentage of total body surface area), age of the individual and accompanied smoke inhalation. Essential treatment for the burn victims remains the resuscitation with intravenous fluids to maintain optimal fluid balance, nutrition optimisation, wound coverage, and pain control (3).
    [Show full text]
  • Federal Register/Vol. 82, No. 13/Monday, January 23, 2017/Proposed Rules
    8004 Federal Register / Vol. 82, No. 13 / Monday, January 23, 2017 / Proposed Rules DEPARTMENT OF HEALTH AND comment will be made public, you are www.regulations.gov. Submit both HUMAN SERVICES solely responsible for ensuring that your copies to the Division of Dockets comment does not include any Management. If you do not wish your Food and Drug Administration confidential information that you or a name and contact information to be third party may not wish to be posted, made publicly available, you can 21 CFR Part 1132 such as medical information, your or provide this information on the cover [Docket No. FDA–2016–N–2527] anyone else’s Social Security number, or sheet and not in the body of your confidential business information, such comments and you must identify this Tobacco Product Standard for N- as a manufacturing process. Please note information as ‘‘confidential.’’ Any Nitrosonornicotine Level in Finished that if you include your name, contact information marked as ‘‘confidential’’ Smokeless Tobacco Products information, or other information that will not be disclosed except in identifies you in the body of your accordance with 21 CFR 10.20 and other AGENCY: Food and Drug Administration, comments, that information will be applicable disclosure law. For more HHS. posted on http://www.regulations.gov. information about FDA’s posting of • ACTION: Proposed rule. If you want to submit a comment comments to public dockets, see 80 FR with confidential information that you 56469, September 18, 2015, or access SUMMARY: The Food and Drug do not wish to be made available to the the information at: http://www.fda.gov/ Administration (FDA) is proposing a public, submit the comment as a regulatoryinformation/dockets/ tobacco product standard that would written/paper submission and in the default.htm.
    [Show full text]
  • Evaluating the Real-World Effectiveness of Bupropion Versus Varenicline for Smoking Cessation: Exploring the Role of Nicotine Metabolism and Medication Adherence
    Evaluating the Real-World Effectiveness of Bupropion Versus Varenicline for Smoking Cessation: Exploring the Role of Nicotine Metabolism and Medication Adherence By Jiahui Zhang A thesis submitted in conformity with the requirements for the degree of Master of Science Graduate Department of Pharmacology and Toxicology University of Toronto © Copyright by Jiahui Zhang (2017) Evaluating the Real-World Effectiveness of Bupropion Versus Varenicline for Smoking Cessation: Exploring the Role of Nicotine Metabolism and Medication Adherence Jiahui Zhang Degree of Master of Science Graduate Department of Pharmacology and Toxicology University of Toronto ABSTRACT Bupropion and varenicline are effective, first-line prescription-only pharmacotherapies for smoking cessation; however, their real-world use is limited by affordability and accessibility. Using a novel internet-based randomized design, we evaluated the real-world effectiveness of mailed bupropion and varenicline, as well as the roles of nicotine metabolism (NMR) and medication adherence, in a sample of interested smokers using web-based recruitment and follow up. Quit rates at end of treatment (EOT) were significantly higher for varenicline (30.2%) compared to bupropion (19.6%). Quit rates at 6 months (14.0%) and 12 months (12.1%) were not significantly different between bupropion and varenicline. Increased medication compliance significantly improved cessation outcomes at EOT. NMR was associated with nicotine dependence. Varenicline benefited Slow Metabolizers of nicotine whilst bupropion benefited Normal Metabolizers. Even though real-world quit rates were comparable to clinical trials, improving medication compliance and implementing personalized pharmacological and behavioral interventions are promising approaches to increase efficacy of smoking cessation pharmacotherapies. ii ACKNOWLEDGEMENTS First and foremost, I would like to express my sincerest appreciation to my supervisor, Dr.
    [Show full text]
  • Family Smoking Prevention and Tobacco Control Act’’
    H. R. 1256 One Hundred Eleventh Congress of the United States of America AT THE FIRST SESSION Begun and held at the City of Washington on Tuesday, the sixth day of January, two thousand and nine An Act To protect the public health by providing the Food and Drug Administration with certain authority to regulate tobacco products, to amend title 5, United States Code, to make certain modifications in the Thrift Savings Plan, the Civil Service Retirement System, and the Federal Employees’ Retirement System, and for other purposes. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, DIVISION A—FAMILY SMOKING PRE- VENTION AND TOBACCO CONTROL ACT SECTION 1. SHORT TITLE; TABLE OF CONTENTS. (a) SHORT TITLE.—This division may be cited as the ‘‘Family Smoking Prevention and Tobacco Control Act’’. (b) TABLE OF CONTENTS.—The table of contents of this division is as follows: Sec. 1. Short title; table of contents. Sec. 2. Findings. Sec. 3. Purpose. Sec. 4. Scope and effect. Sec. 5. Severability. Sec. 6. Modification of deadlines for Secretarial action. TITLE I—AUTHORITY OF THE FOOD AND DRUG ADMINISTRATION Sec. 101. Amendment of Federal Food, Drug, and Cosmetic Act. Sec. 102. Final rule. Sec. 103. Conforming and other amendments to general provisions. Sec. 104. Study on raising the minimum age to purchase tobacco products. Sec. 105. Enforcement action plan for advertising and promotion restrictions. Sec. 106. Studies of progress and effectiveness. TITLE II—TOBACCO PRODUCT WARNINGS; CONSTITUENT AND SMOKE CONSTITUENT DISCLOSURE Sec. 201. Cigarette label and advertising warnings.
    [Show full text]
  • Tool 2. Stakeholder-Specific Arguments for Tobacco Control
    TOOL 2. STAKEHOLDER-SPECIFIC ARGUMENTS FOR TOBACCO CONTROL This tool provides arguments to convince different sectors and stakeholders to support and actively engage in tobacco control and actively participate in the NCM. The tool will also help health ministry officials answer questions from representatives of other sectors, and articulate a clear vision for why a whole-of-government approach is critical for tobacco control and related sustainable development objectives. Efforts to generate whole-of-government responses to tobacco control typically fail where tobacco is presented as a health challenge only. NCM engagement should be presented as more than just a benefit to, and responsibility of, the health sector. Clear, convincing and sector-specific arguments can take several forms, discussed below. Those involved in tobacco control planning should consider which line of argument or combination of arguments is most likely to persuade in a given context. The first argument is to emphasize whole-of-government efforts and policy coherence as necessary to fulfill WHO FCTC obligations. Entire governments sign the WHO FCTC, and thus it is legally incumbent upon all relevant government sectors to implement the treaty’s provisions. This means that different sectors are legally obliged to reconcile any contradictions between their mandates and the WHO FCTC. That the WHO FCTC is a legally binding international treaty, with reporting requirements, should be considered in priority setting discussions across ministries. Ministries could also be
    [Show full text]
  • July 16, 2018 VIA ELECTRONIC SUBMISSION and HAND DELIVERY Division of Dockets Management Food and Drug Administration 5630 Fishe
    Jose Luis Murillo Vice President Regulatory Affairs July 16, 2018 VIA ELECTRONIC SUBMISSION AND HAND DELIVERY Division of Dockets Management Food and Drug Administration 5630 Fishers Lane, Rm. 1061 Rockville, MD 20852 Re: Docket No. FDA-2017-N-6189 (83 Fed. Reg. 11,818, March 16, 2018) Advance Notice of Proposed Rulemaking on Tobacco Product Standard for Nicotine Level of Certain Tobacco Products Altria Client Services (“ALCS”), on behalf of Philip Morris USA Inc. (“PM USA”), John Middleton Company (“JMC”), and Sherman Group Holdings LLC and its subsidiaries (“Nat Sherman”),1 submits these comments to the Food and Drug Administration’s (“FDA’s” or the “Agency’s”) Advance Notice of Proposed Rulemaking (“ANPRM”) on a Tobacco Product Standard for Nicotine Level of Certain Tobacco Products. The ANPRM comes within the context of an industry in the midst of transformative change. Cigarette smoking is at historically low levels and continues to decline. At the same time, a new market is emerging in innovative noncombustible tobacco products that are potentially less harmful than cigarettes. There is now a scientific consensus that noncombustible products, like e-vapor, are substantially less risky than conventional cigarettes. It is smoke, and not nicotine, that causes most tobacco- related harm. And adult smokers are increasingly expressing interest in switching from cigarettes to less risky alternatives. We agree that a nicotine product standard of some sort may make sense in a future regulatory system, but this requires the pre-existence of a marketplace with alternative, FDA-authorized, reduced risk products; more information about the relative risks of those products; and a regulatory system that respects the rights of adults to make decisions based on accurate information.
    [Show full text]
  • A Toxicological Review of the Products of Combustion
    HPA-CHaPD-004 A Toxicological Review of the Products of Combustion J C Wakefield ABSTRACT The Chemical Hazards and Poisons Division (CHaPD) is frequently required to advise on the health effects arising from incidents due to fires. The purpose of this review is to consider the toxicity of combustion products. Following smoke inhalation, toxicity may result either from thermal injury, or from the toxic effects of substances present. This review considers only the latter, and not thermal injury, and aims to identify generalisations which may be made regarding the toxicity of common products present in fire smoke, with respect to the combustion conditions (temperature, oxygen availability, etc.), focusing largely on the adverse health effects to humans following acute exposure to these chemicals in smoke. The prediction of toxic combustion products is a complex area and there is the potential for generation of a huge range of pyrolysis products depending on the nature of the fire and the conditions of burning. Although each fire will have individual characteristics and will ultimately need to be considered on a case by case basis there are commonalities, particularly with regard to the most important components relating to toxicity. © Health Protection Agency Approval: February 2010 Centre for Radiation, Chemical and Environmental Hazards Publication: February 2010 Chemical Hazards and Poisons Division £15.00 Chilton, Didcot, Oxfordshire OX11 0RQ ISBN 978-0-85951- 663-1 This report from HPA Chemical Hazards and Poisons Division reflects understanding and evaluation of the current scientific evidence as presented and referenced in this document. EXECUTIVE SUMMARY The Chemical Hazards and Poisons Division (CHaPD) is frequently required to advise on the health effects arising from incidents due to fires.
    [Show full text]
  • Impact-Of-Tobacco-Use-On-Cancer-In
    Page 2 Executive Summary Tobacco use remains the world’s most preventable cause of death. Despite decades of declines in cigarette smoking prevalence, almost one-third of cancer deaths in the United States are still caused by smoking. This report describes the prevalence of tobacco use and its impact on cancers associated with tobacco use in Ohio. Key findings from this report include: • In 2016, 22.5 percent of Ohio adults ages 18 and older were current cigarette smokers compared to the median prevalence of 17.1 percent in the United States. • In Ohio in 2016, 2.7 percent of Ohio adults were cigar smokers, 5.7 percent used electronic cigarettes and 4.7 percent used smokeless tobacco. • The prevalence of current smoking among Ohio adults has decreased over the past 20 years. Groups for which the prevalence of current smoking was higher in 2016 include those ages 25 to 44, males, those with lower household income and education, lesbian, gay, bisexual and transgender adults, and those who have a disability or poor mental health. • County-level smoking prevalence among adult residents of Ohio ranged from 14 percent to 25 percent. Smoking was more common among residents of southern counties in Ohio. Cancer incidence and mortality rates were also highest in southern Ohio as well as southeastern Ohio. • Cigarette use among Ohio high school students decreased 74.5 percent from 2000 to 2016; however, this may partially be due to the increase in -e cigarette use in youth. • According to the U.S. Surgeon General, tobacco smoking is associated with 12 cancer sites/types.
    [Show full text]
  • Family Smoking Prevention and Tobacco Control and Federal Retirement Reform
    PUBLIC LAW 111–31—JUNE 22, 2009 FAMILY SMOKING PREVENTION AND TOBACCO CONTROL AND FEDERAL RETIREMENT REFORM VerDate Nov 24 2008 08:41 Jun 25, 2009 Jkt 079139 PO 00031 Frm 00001 Fmt 6579 Sfmt 6579 E:\PUBLAW\PUBL031.111 APPS06 PsN: PUBL031 dkrause on GSDDPC29 with PUBLIC LAWS 123 STAT. 1776 PUBLIC LAW 111–31—JUNE 22, 2009 Public Law 111–31 111th Congress An Act To protect the public health by providing the Food and Drug Administration with certain authority to regulate tobacco products, to amend title 5, United States June 22, 2009 Code, to make certain modifications in the Thrift Savings Plan, the Civil Service [H.R. 1256] Retirement System, and the Federal Employees’ Retirement System, and for other purposes. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, Family Smoking DIVISION A—FAMILY SMOKING PRE- Prevention and Tobacco Control VENTION AND TOBACCO CONTROL Act. ACT SECTION 1. SHORT TITLE; TABLE OF CONTENTS. 21 USC 301 note. (a) SHORT TITLE.—This division may be cited as the ‘‘Family Smoking Prevention and Tobacco Control Act’’. (b) TABLE OF CONTENTS.—The table of contents of this division is as follows: Sec. 1. Short title; table of contents. Sec. 2. Findings. Sec. 3. Purpose. Sec. 4. Scope and effect. Sec. 5. Severability. Sec. 6. Modification of deadlines for Secretarial action. TITLE I—AUTHORITY OF THE FOOD AND DRUG ADMINISTRATION Sec. 101. Amendment of Federal Food, Drug, and Cosmetic Act. Sec. 102. Final rule. Sec. 103. Conforming and other amendments to general provisions.
    [Show full text]
  • WO 2016/001643 Al 7 January 2016 (07.01.2016) P O P C T
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2016/001643 Al 7 January 2016 (07.01.2016) P O P C T (51) International Patent Classification: (74) Agents: GILL JENNINGS & EVERY LLP et al; The A61P 25/28 (2006.01) A61K 31/194 (2006.01) Broadgate Tower, 20 Primrose Street, London EC2A 2ES A61P 25/16 (2006.01) A61K 31/205 (2006.01) (GB). A23L 1/30 (2006.01) (81) Designated States (unless otherwise indicated, for every (21) International Application Number: kind of national protection available): AE, AG, AL, AM, PCT/GB20 15/05 1898 AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, (22) International Filing Date: DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, 29 June 2015 (29.06.2015) HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, (25) Filing Language: English KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, (26) Publication Language: English PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, (30) Priority Data: SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, 141 1570.3 30 June 2014 (30.06.2014) GB TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. 1412414.3 11 July 2014 ( 11.07.2014) GB (84) Designated States (unless otherwise indicated, for every (71) Applicant: MITOCHONDRIAL SUBSTRATE INVEN¬ kind of regional protection available): ARIPO (BW, GH, TION LIMITED [GB/GB]; 39 Glasslyn Road, London GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, N8 8RJ (GB).
    [Show full text]